Charting India Pharma Inc’s growth path
Pharma leaders and experts highlight opportunities in the life sciences industry, address critical issues and explore development…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Group
US FDA grants Orphan Drug Designation to Zydus’ Saroglitazar for primary biliary cholangitis…
This follows the grant of ‘Fast Track Designation’ by the USFDA to Saroglitazar Mg for PBC in December 2020
‘Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs’
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates at $2,405.42 million to India in 2018-19
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad
Zydus Cadila acquires select animal health brands of Zoetis
The acquisition will help Zydus expand its animal health business in India